IOVAIovance Biotherapeutics, Inc.
$14.61+613% 1Y
$14.61
$1.8152 weeks$14.79
Is it growing?
Good
2 good, 1 without dataGrowing: revenue growing +35% year on year and operating margin widening (+78.5 points).
Revenue trend+35% in a year
Trailing-twelve-month revenue vs a year earlier, from the company's own filings.
Margin direction+78.5 points operating
Trailing-twelve-month operating margin, -97.8% now against -176.3% a year earlier.
All from SEC EDGAR, as of Jun 30, 2026.
Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.
Is IOVA growing?
- Years of annual history on file
- 18
Years of annual history on file · FY2008 to FY2025, as filed
Details›
- Revenue FY2023
- $1.2M
- Revenue FY2024
- $164M
- Revenue FY2025
- $264M
Annual income statements as filed with the SEC.
On our screens:Most shorted stocks